ATOH1
Basic information
Region (hg38): 4:93828753-93830964
Links
Phenotypes
GenCC
Source:
- hearing loss, autosomal dominant 89 (Limited), mode of inheritance: AD
- hearing loss, autosomal dominant 89 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal dominant 89 | AD | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic | 33111345 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hearing loss, autosomal dominant 89 (1 variants)
- Dominant progressive sensorineural hearing loss (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATOH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 42 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 1 | 43 | 0 | 4 |
Variants in ATOH1
This is a list of pathogenic ClinVar variants found in the ATOH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-93828948-G-C | not specified | Uncertain significance (Dec 19, 2022) | ||
4-93828983-C-A | not specified | Uncertain significance (Mar 11, 2022) | ||
4-93828999-C-G | ATOH1-related disorder | Uncertain significance (Sep 04, 2024) | ||
4-93828999-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
4-93829059-G-C | not specified | Uncertain significance (Jul 13, 2021) | ||
4-93829061-G-A | ATOH1-related disorder | Likely benign (Jun 26, 2019) | ||
4-93829075-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
4-93829076-G-A | ATOH1-related disorder | Benign (Dec 09, 2019) | ||
4-93829105-A-T | not specified | Uncertain significance (Dec 27, 2023) | ||
4-93829113-G-A | not specified | Uncertain significance (Apr 12, 2022) | ||
4-93829144-G-A | Hearing loss, autosomal dominant 89 | Uncertain significance (Sep 05, 2024) | ||
4-93829180-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
4-93829209-C-T | ATOH1-related disorder • not specified | Uncertain significance (Jan 12, 2024) | ||
4-93829213-G-T | not specified | Uncertain significance (Jun 01, 2023) | ||
4-93829218-G-A | not specified | Uncertain significance (Jan 18, 2025) | ||
4-93829228-G-C | not specified | Uncertain significance (Oct 16, 2024) | ||
4-93829252-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
4-93829256-C-A | not specified | Uncertain significance (May 08, 2024) | ||
4-93829264-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
4-93829340-C-G | ATOH1-related disorder | Benign (Jun 27, 2018) | ||
4-93829344-C-A | not specified | Uncertain significance (Sep 24, 2024) | ||
4-93829357-G-A | not specified | Uncertain significance (Dec 04, 2023) | ||
4-93829368-C-T | ATOH1-related disorder | Uncertain significance (Feb 13, 2024) | ||
4-93829392-G-T | not specified | Uncertain significance (Dec 27, 2023) | ||
4-93829407-C-G | Pontoneocerebellar hypoplasia;Global developmental delay;Hearing loss • See cases | Uncertain significance (May 02, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATOH1 | protein_coding | protein_coding | ENST00000306011 | 1 | 1180 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0178 | 0.902 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.134 | 215 | 210 | 1.03 | 0.00000942 | 2273 |
Missense in Polyphen | 66 | 82.323 | 0.80172 | 933 | ||
Synonymous | -1.46 | 113 | 94.9 | 1.19 | 0.00000446 | 768 |
Loss of Function | 1.48 | 4 | 8.70 | 0.460 | 3.70e-7 | 99 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator. Activates E box-dependent transcription in collaboration with TCF3/E47, but the activity is completely antagonized by the negative regulator of neurogenesis HES1. Plays a role in the differentiation of subsets of neural cells by activating E box-dependent transcription (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.283
Intolerance Scores
- loftool
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.26
Haploinsufficiency Scores
- pHI
- 0.768
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.577
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atoh1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- atoh1a
- Affected structure
- neuromast hair cell
- Phenotype tag
- abnormal
- Phenotype quality
- absent
Gene ontology
- Biological process
- neuron migration;transcription by RNA polymerase II;Notch signaling pathway;axon guidance;central nervous system development;cerebral cortex development;inner ear morphogenesis;auditory receptor cell fate specification;auditory receptor cell fate determination;negative regulation of apoptotic process;positive regulation of inner ear auditory receptor cell differentiation;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;chromatin DNA binding;protein dimerization activity